Edward B Stelow
Overview
Explore the profile of Edward B Stelow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
162
Citations
2757
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kunk P, Dougherty S, Lynch K, Whitehair R, Meneveau M, Obeid J, et al.
J Immunother
. 2021 Jun;
44(7):254-263.
PMID: 34191790
Cholangiocarcinoma (CC) is an uncommon malignancy with increasing incidence and dismal prognosis. We conducted a comprehensive analysis of the CC tumor immune microenvironment (TIME) based on tumor location to identify...
12.
Ju J, Stelow E, Courville E
Semin Diagn Pathol
. 2021 Mar;
38(4):6-13.
PMID: 33726961
The luminal gastrointestinal tract can be a site of robust immune response in which reactive lymphoproliferative processes can sometimes be difficult to distinguish from lymphoma. In this article, we review...
13.
Mondal T, Shivange G, Tihagam R, Lyerly E, Battista M, Talwar D, et al.
EMBO Mol Med
. 2021 Feb;
13(3):e12716.
PMID: 33587338
Lack of effective immune infiltration represents a significant barrier to immunotherapy in solid tumors. Thus, solid tumor-enriched death receptor-5 (DR5) activating antibodies, which generates tumor debulking by extrinsic apoptotic cytotoxicity,...
14.
Whitehair R, Stelow E
Diagn Cytopathol
. 2020 Oct;
49(2):287-294.
PMID: 33128511
Background: The classification of epithelioid pancreatic neoplasms based on fine-needle aspiration (FNA) is important for proper management, as distinction of pancreatic neuroendocrine neoplasms from other similar appearing lesions can result...
15.
Coppock J, Mills A, Stelow E
Head Neck Pathol
. 2020 Jun;
15(1):163-168.
PMID: 32564273
Despite higher stages at presentation, patients with high-risk (HR) HPV-related (HPV+) head and neck squamous cell carcinomas (HNSCCs) have better survival rates compared to those with non-HPV-related (HPV-) disease. However,...
16.
Gottlieb C, Pinsky B, Mills A, Stelow E
Diagn Cytopathol
. 2020 Feb;
48(5):489-490.
PMID: 32043839
No abstract available.
17.
Ju J, Dibbern M, Mahadevan M, Fan J, Kunk P, Stelow E
Am J Clin Pathol
. 2019 Dec;
153(5):598-604.
PMID: 31844887
Objectives: Although germline mutations of mismatch repair (MMR) genes (Lynch syndrome) are not typically associated with cholangiocarcinomas, the US Food and Drug Administration recently approved the use of pembrolizumab in...
18.
Wong K, Jo V, Lowe A, Faquin W, Renshaw A, Shah A, et al.
Cancer Cytopathol
. 2019 Nov;
128(1):68-75.
PMID: 31751003
Background: Hürthle cell metaplasia is common in hyperplastic nodules, particularly within the setting of lymphocytic thyroiditis (LT). The Bethesda System for Reporting Thyroid Cytopathology indicates that it is acceptable to...
19.
Mehrad M, Stelow E, Bishop J, Wang X, Haynes W, Oliver D, et al.
Am J Surg Pathol
. 2019 Nov;
44(3):340-346.
PMID: 31743131
Sinonasal inverted papillomas (IPs) commonly recur, and transform to malignancy in 5% to 10% of patients. It has long been debated whether IPs are caused by high-risk or low-risk (lr)...
20.
McHugh K, Stelow E, Harrison G, Policarpio-Nicolas M
Cancer Cytopathol
. 2019 Oct;
127(11):700-707.
PMID: 31584754
Background: Solid pseudopapillary neoplasm (SPN) is an uncommon tumor that is challenging to diagnose on cytology due to morphologic overlap with other pancreatic neoplasms. Recently, putative diagnostic markers for SPN...